Gene therapy with AAV2-CDNF provides functional benefits in a rat model of Parkinson's disease.
Bäck S, Peränen J, Galli E, Pulkkila P, Lonka-Nevalaita L, Tamminen T, Voutilainen MH, Raasmaja A, Saarma M, Männistö PT, et al. Brain Behav. 2013 Mar; 3(2):75-88. Epub 2013 Jan 14.